Hysteroscopic surgery
Conditions
Interventions
Oliceridine group:Intravenous injection of oliceridine at a dose of 20 µg/kg
Sufentanil Group:Intravenous injection of sufentanil at a dose of 0.1 µg/kg
Sponsors
Chinese People's Liberation Army Northern Theater Command General Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1 Scheduled to undergo hysteroscopic surgery under general anesthesia; 2 Aged 18–60 years; 3 American Society of Anesthesiologists (ASA) physical status classification I–II; 4 Body Mass Index (BMI) 18.5–28.0 kg/m^2.
Exclusion criteria
Exclusion criteria: 1 Patients with severe hepatic or renal insufficiency, or coagulation disorders. 2 Patients with cardiopulmonary diseases (such as hypertension, arrhythmia, coronary heart disease, bradycardia, asthma, etc.). 3 Patients with a history of moderate to severe motion sickness or a history of severe nausea and vomiting. 4 Patients with a history of mental illness or cognitive impairment. 5 Patients with allergies or contraindications to the drugs planned for anesthesia. 6 Patients assessed preoperatively as having a difficult airway.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of respiratory depression; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anesthesia-Related Time;Dosage of Propofol;Incidence of other adverse reactions;Vital sign; | — |
Countries
China
Contacts
Public ContactHuijuan Cao
The General Hospital of the PLA Northern Theater Command
Outcome results
None listed